Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Nanomedicine. 2013;8:2521-32. doi: 10.2147/IJN.S43770. Epub 2013 Jul 17.

Intravenous magnetic nanoparticle cancer hyperthermia.

Author information

  • 1Nanoprobes, Yaphank, NY, USA.

Abstract

Magnetic nanoparticles heated by an alternating magnetic field could be used to treat cancers, either alone or in combination with radiotherapy or chemotherapy. However, direct intratumoral injections suffer from tumor incongruence and invasiveness, typically leaving undertreated regions, which lead to cancer regrowth. Intravenous injection more faithfully loads tumors, but, so far, it has been difficult achieving the necessary concentration in tumors before systemic toxicity occurs. Here, we describe use of a magnetic nanoparticle that, with a well-tolerated intravenous dose, achieved a tumor concentration of 1.9 mg Fe/g tumor in a subcutaneous squamous cell carcinoma mouse model, with a tumor to non-tumor ratio > 16. With an applied field of 38 kA/m at 980 kHz, tumors could be heated to 60°C in 2 minutes, durably ablating them with millimeter (mm) precision, leaving surrounding tissue intact.

KEYWORDS:

alternating magnetic field; cancer; hyperthermia; intravenous delivery; magnetic nanoparticles

PMID:
23901270
[PubMed - indexed for MEDLINE]
PMCID:
PMC3720579
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk